SERUM INSULIN AND CRP AS PREDICTORS OF GLYCEMIC CONTROL IN TYPE 2 DIABETIC PATIENTS
Main Article Content
Keywords
Type 2 Diabetes Mellitus, Insulin, CRP, Glycemic Control, Hyperinsulinemia
Abstract
Background: Type 2 Diabetes Mellitus (T2DM) is a complex metabolic disorder characterized by insulin resistance and chronic low-grade inflammation. In India alone, over 72 million individuals currently live with diabetes, and this number is projected to nearly double by 2045.
Objectives: In this study, we aimed to investigate the correlation between serum insulin and CRP levels with HbA1c in T2DM patients to assess their predictive value in determining glycemic control.
Materials and Methods: A hospital-based cross-sectional observational study included on 100 T2DM patients aged 20-65 years. Fasting serum insulin and CRP levels were measured and correlated with glycemic status.
Results: The results showed that poor glycemic control was significantly associated with elevated CRP and fasting insulin levels.
Conclusion: These findings suggest that insulin resistance and inflammation play pivotal roles in the pathophysiology of T2DM and that CRP and insulin may serve as useful biomarkers in predicting glycemic control.
References
[2] Meriga RK et al. Correlation between glycemic control, lipid profile and C-reactive protein in adults with type 2 diabetes mellitus (Nellore, India). Int J Adv Med. 2020;7(9):1312–1317.
[3] Reed J, Bain S, Kanamarlapaudi. A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives. Diabetes Metab Syndr Obes; 2021; 14: 3567 – 3602.
[4] Gupta AK, Saxena R, Mahajan A, Bamniya S. Comparative Analysis of Serum Insulin, Insulin Resistance and Inflammatory Markers in Type 2 Diabetes Mellitus Patients and Healthy Controls. International Journal of Pharmaceutical and Clinical Research; 2025; 17(1): 323-327.
[5] Kulkarni AP, Jain M, Bhalerao SD. Association of fasting glucose and fasting insulin levels: Insights into the mechanism of pre-diabetes. Natl J Physiol Pharmacol.; 2023; 13(12): 2516- 2519.
[6] Sproston R N, Ashworth J J. Role of C - reactive protein at Sites of Inflammation and Infection. Frontiers in Immunology; 2018; 9: 1 – 11.
[7] Rakesh Kumar R et al. hs-CRP and glycemic status in T2DM: Patna study. SJH Research Africa. 2024;5(3).
[8] Bell DS et al. Commentary on CRP and glycemia link. Diabetes Care. 2004;27(2):637.
[9] Reddy KSS, Varadaraj P, Nallusamy G, Senthilnathan S. Correlation between HbA1c and hs- CRP in myocardial infarction patients and their six month mortality follw-up. Cureus; 2024; 16(8): e67070. doi 10.7759/cureus.67070.
[10] Brunner EJ, Kivimaki M, Lawlor DW, Smith GD, Cooper JA, Shah T, et al. Inflammation, insulin resistance, and diabetes – Mendelian randomization using CRP haplotypes points upstream. PLoS Med; 2008; 5(8): e155.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Arvind Kumar Gupta
Demonstrator, Department of Biochemistry, RD Gardi Medical College, Ujjain, M.P.
Dr. Nikhil Rajak
Assistant Professor, Department of Biochemistry, RD Gardi Medical College, Ujjain, M.P.
Dr. Anurag Kesarwani
Professor & Head, Department of Biochemistry, Saraswati Medical College, Unnao, U.P.
Simran Bamniya
Demonstrator, Department of Biochemistry, JIET Medical College, Jodhpur, Rajasthan
Raashika Saxena
Tutor, Department of Biochemistry, Dr. Ulhas Patil Medical College & Hospital, Jalgaon, Maharashtra